セレイドセラピューティクス - 細胞治療(造血幹細胞)
JP
EN
TOP
About Celaid
About Celaid
Message
Management Philosophy
Corporate Profile
Access
Member
Technology & Innovation
Technology & Innovation
About hematopoietic stem cells
What are hematopoietic stem cells
The growing need for the application of hematopoietic stem cells in cell therapy
Challenges in hematopoietic stem cell transplants
Our technologies
In-vitro expansion technology
Our areas of technological excellence
Our Business
Our Business
Our goals
The development of new cell therapies for the treatment of leukemia and other blood cancers and genetic disorders
Support for regenerative medicine and drug discovery research around the world
Business model
Platform technology development and clinical development
The value chain
News
News
Contact
Contact
Privacy
Policy
JP
Japanese
EN
English
News
Home
News
2022
11
NEWS
news
2022.11.30
Selected as a final nominee for the "Japan Venture Award".
news
2022.11.22
Celaid will be speaking at the "JHVS2022 Global Business Pitch Session", sponsored by the MHLW
news
2022.11.01
Celaid selected as a finalist in the "Japan Healthcare Business Contest (JHeC) 2023" organized by METI.
Copyright© セレイドセラピューティクス - 細胞治療(造血幹細胞) , 2024 All Rights Reserved Powered by
STINGER
.
